Tag - EMA

GHP News Latest Science

Vaccines and vaccination news

Global WHO and public health WHO’s Technical Advisory Group on COVID-19 Vaccine Composition (TAG‑CO‑VAC) is preparing its next decision on updated COVID‑19 vaccine antigen composition, with a meeting scheduled for May...

14 April, 2026

4 min read

GHP News Latest Science

VacciNEWS around the globe

EMA backs first mRNA flu–COVID combination vaccine for older adults The EMA’s CHMP has issued a positive opinion for Moderna’s mRNA combination vaccine “mCombriax,” targeting both seasonal influenza and COVID‑19 in...

19 March, 2026

5 min read

GHP News Latest Science

Hepatitis A vaccines in the Western world (EMA- or FDA-licensed)

In short, all Western inactivated vaccines are highly immunogenic with an excellent safety profile, with very good long-term protection after the full series. Single-dose schedules are used in some Latin American...

3 July, 2025

1 min read

GHP News

EMA aims to develop guideline for mRNA vaccines

The European Medicines Agency (EMA) has created a concept paper that addresses the need to establish a guideline on the quality aspects of messenger RNA (mRNA) vaccines, emphasizing the number of clinical trial...

13 July, 2023

1 min read

Latest Science

ECDC and EMA issue advice on fourth doses of mRNA COVID-19 vaccines

The European Centre for Disease Prevention and Control (ECDC) and EMA’s COVID-19 task force (ETF) have concluded that it is too early to consider using a fourth dose of mRNA COVID-19 vaccines (Pfizer’s Comirnaty and...

7 April, 2022

3 min read